Literature DB >> 34327671

Association between public media and trends in new acute coronary syndrome presentations during the first COVID‑19 wave in the Netherlands.

L Derks1, H N Sturkenboom2, M Zaal3, S Houterman4, P Woudstra5, R A Tio2, H P A van Veghel4.   

Abstract

BACKGROUND: We aimed to evaluate the association between public media and trends in new presentations of acute coronary syndrome (ACS) during the first wave of the coronavirus disease 2019 (COVID‑19) in the Netherlands.
METHODS: New ACS presentations per week in 73 hospitals during the first half of 2019 and 2020 were retrieved from the national organisation Dutch Hospital Data and incidence rates were calculated. Stratified analyses were performed by region, type of ACS and patient characteristics.
RESULTS: After the first confirmed COVID‑19 case and during lockdown, numbers declined by up to 41% (95% confidence interval (CI): 36-47%) compared to 2019. This reduction was more pronounced for non-ST-segment elevation myocardial infarction (NSTEMI) (48%; 95% CI: 39-55%) and unstable angina (UA; 50%; 95% CI: 40-59%) than for STEMI (34%; 95% CI: 23-43%). There was no association between ACS and COVID‑19 incidence rate per region. After the steep decline, a public campaign encouraged patients not to postpone hospital visits. Numbers then increased, without a rebound effect. Trends were similar irrespective of sex, age or socio-economic status. During the outbreak, compared to coronary artery bypass graft procedures, relatively more (acute) percutaneous coronary interventions for NSTEMI and UA were performed.
CONCLUSION: New ACS presentations decreased by up to 41%. Lockdown measures and public campaigns, rather than COVID‑19 incidence, were associated with significant changes in new ACS presentations. Even though causality cannot be established, this emphasises the role of the public media and healthcare organisations in informing patients to prevent underdiagnoses of ACS and associated health damage.
© 2021. The Author(s).

Entities:  

Keywords:  Acute coronary syndrome; COVID‑19; Non-ST-segment elevation myocardial infarction; ST-segment elevation myocardial infarction; Unstable angina

Year:  2021        PMID: 34327671     DOI: 10.1007/s12471-021-01603-5

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  2 in total

1.  Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network.

Authors:  Andreas Bollmann; Sven Hohenstein; Andreas Meier-Hellmann; Ralf Kuhlen; Gerhard Hindricks
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2020-07-01

2.  Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the Global Burden of Disease Study 2017.

Authors:  Haijiang Dai; Quanyu Zhang; Arsalan Abu Much; Elad Maor; Amit Segev; Roy Beinart; Salim Adawi; Yao Lu; Nicola Luigi Bragazzi; Jianhong Wu
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2021-10-28
  2 in total
  3 in total

1.  Comparison of trends in Clostridioides difficile infections in hospitalised patients during the first and second waves of the COVID-19 pandemic: A retrospective sentinel surveillance study.

Authors:  Karuna E W Vendrik; Amoe Baktash; Jelle J Goeman; Céline Harmanus; Daan W Notermans; Sabine C de Greeff; Ed J Kuijper
Journal:  Lancet Reg Health Eur       Date:  2022-06-28

2.  Ongoing COVID-19 Pandemic Effects on Admissions and In-Hospital Outcomes in Patients With ST-Elevation Myocardial Infarction (STEMI): An Albanian Observational Study.

Authors:  Leonard Simoni; Ilir Alimehmeti; Astrit Ceka; Ermir A Tafaj; Mirald Gina; Aldo Panariti; Fatjon Xhafaj; Alban Dibra; Artan Goda
Journal:  Cureus       Date:  2022-07-13

3.  Effects of Video-Based Patient Education and Consultation on Unplanned Health Care Utilization and Early Recovery After Coronary Artery Bypass Surgery (IMPROV-ED): Randomized Controlled Trial.

Authors:  Gijs van Steenbergen; Dennis van Veghel; Dideke van Lieshout; Merel Sperwer; Joost Ter Woorst; Lukas Dekker
Journal:  J Med Internet Res       Date:  2022-08-26       Impact factor: 7.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.